Back

PLN-related obstructive hypertrophic cardiomyopathy responsive to mavacamten

European Heart Journal

6 May 2025
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease

Contributors

Matteo Beltrami
Matteo Beltrami

Author

Careggi Florence , Italy

Giacomo Bonacchi
Giacomo Bonacchi

Author

Maurizio Pieroni
Maurizio Pieroni

Author

You may be interested in
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Congress Session
Novel mechanisms in arrhythmogenic cardiac diseases
2 September 2024
thumbnail
Congress Session
Taking a deeper dive in cardiomyopathies
19 May 2025
thumbnail
Congress Presentation
Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources